Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo

BMB Reports

Volumn 47, Issue 6, 2014, Pages 336-341

  Ku, Sae Kwang ^a   Han, Min Su ^b   Lee, Min Young ^c   Lee, You Mie ^c   Bae, Jong Sup ^c  

^a Daegu Haany University   (South Korea)

^b Daegu Fatima Hospital   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

CLP; EPCR shedding; Oroxylin A; PMA

Indexed keywords

5,7-DIHYDROXY-6-METHOXY-2-PHENYLCHROMEN-4-ONE; ACTIVATED PROTEIN C RECEPTOR; ADAM PROTEIN; BLOOD CLOTTING FACTOR; CELL SURFACE RECEPTOR; FLAVONOID; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; DOWN REGULATION; DRUG EFFECTS; HUMAN; MALE; METABOLISM; MOUSE; PHOSPHORYLATION; SCUTELLARIA BAICALENSIS; SEPSIS; UMBILICAL VEIN ENDOTHELIAL CELL;

ADAM PROTEINS; ANIMALS; BLOOD COAGULATION FACTORS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FLAVONOIDS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTORS, CELL SURFACE; SCUTELLARIA BAICALENSIS; SEPSIS; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903600511     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2014.47.6.198     Document Type: Article

References (30)

1. Fukudome, K. and Esmon, C. T. (1994) Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J. Biol. Chem. 269, 26486-26491.
2. Fukudome, K., Kurosawa, S., Stearns-Kurosawa, D. J., He, X., Rezaie, A. R. and Esmon, C. T. (1996) The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor. J. Biol. Chem. 271, 17491-17498.
3. Mosnier, L. O., Zlokovic, B. V. and Griffin, J. H. (2007) The cytoprotective protein C pathway. Blood 109, 3161-3172.
4. Esmon, C. T. (2004) Structure and functions of the endothelial cell protein C receptor. Crit. Care. Med. 32, S298-301.
5. Wang, L., Bastarache, J. A., Wickersham, N., Fang, X., Matthay, M. A. and Ware, L. B. (2007) Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. Am. J. Respir. Cell Mol. Biol. 36, 497-503.
6. Xu, J., Qu, D., Esmon, N. L. and Esmon, C. T. (2000) Metalloproteolytic release of endothelial cell protein C receptor. J. Biol. Chem. 275, 6038-6044.
7. Kurosawa, S., Stearns-Kurosawa, D. J., Hidari, N. and Esmon, C. T. (1997) Identification of functional endothelial protein C receptor in human plasma. J. Clin. Invest. 100, 411-418.
8. Kurosawa, S., Stearns-Kurosawa, D. J., Carson, C. W., D'Angelo, A., Della Valle, P. and Esmon, C. T. (1998) Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes. Blood 91, 725-727.
9. Ghosh, S., Pendurthi, U. R., Steinoe, A., Esmon, C. T. and Rao, L. V. (2007) Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. J. Biol. Chem. 282, 11849-11857.
10. Lopez-Sagaseta, J., Montes, R., Puy, C., Diez, N., Fukudome, K. and Hermida, J. (2007) Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity. J. Thromb. Haemost. 5, 1817-1824.
11. Menschikowski, M., Hagelgans, A., Eisenhofer, G. and Siegert, G. (2009) Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathways. Exp. Cell Res. 315, 2673-2682.
12. Han, H., Du, B., Pan, X., Liu, J., Zhao, Q., Lian, X., Qian, M. and Liu, M. (2010) CADPE inhibits PMA-stimulated gastric carcinoma cell invasion and matrix metalloproteinase-9 expression by FAK/MEK/ERK-mediated AP-1 activation. Mol. Cancer Res. 8, 1477-1488.
13. Leng, Y., Steiler, T. L. and Zierath, J. R. (2004) Effects of insulin, contraction, and phorbol esters on mitogen-activated protein kinase signaling in skeletal muscle from lean and ob/ob mice. Diabetes. 53, 1436-1444.
14. Huovila, A. P., Turner, A. J., Pelto-Huikko, M., Karkkainen, I. and Ortiz, R. M. (2005) Shedding light on ADAM metalloproteinases. Trends. Biochem. Sci. 30, 413-422.
15. Murphy, G. (2008) The ADAMs: signalling scissors in the tumour microenvironment. Nat. Rev. Cancer 8, 929-941.
16. Li, C., Lin, G. and Zuo, Z. (2011) Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. Biopharm. Drug. Dispos. 32, 427-445.
17. Li, H. N., Nie, F. F., Liu, W., Dai, Q. S., Lu, N., Qi, Q., Li, Z. Y., You, Q. D. and Guo, Q. L. (2009) Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo. Toxicology 257, 80-85.
18. Lu, Z., Lu, N., Li, C., Li, F., Zhao, K., Lin, B. and Guo, Q. (2012) Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway. Toxicol. Lett. 209, 211-220.
19. Sun, Y., Lu, N., Ling, Y., Gao, Y., Chen, Y., Wang, L., Hu, R., Qi, Q., Liu, W., Yang, Y., You, Q. and Guo, Q. (2009) Oroxylin A suppresses invasion through down-regulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells. Eur. J. Pharmacol. 603, 22-28.
20. Tseng, T. L., Chen, M. F., Tsai, M. J., Hsu, Y. H., Chen, C. P. and Lee, T. J. (2012) Oroxylin-A rescues LPS-induced acute lung injury via regulation of NF-kappaB signaling pathway in rodents. PLoS One. 7, e47403.
21. Borgel, D., Bornstain, C., Reitsma, P. H., Lerolle, N., Gandrille, S., Dali-Ali, F., Esmon, C. T., Fagon, J. Y., Aiach, M. and Diehl, J. L. (2007) A comparative study of the protein C pathway in septic and nonseptic patients with organ failure. Am. J. Respir. Crit. Care Med. 176, 878-885.
22. Qu, D., Wang, Y., Song, Y., Esmon, N. L. and Esmon, C. T. (2006) The Ser219-->Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype. J. Thromb. Haemost. 4, 229-235.
23. Qu, D., Wang, Y., Esmon, N. L. and Esmon, C. T. (2007) Regulated endothelial protein C receptor shedding is mediated by tumor necrosis factor-alpha converting enzyme/ADAM17. J. Thromb. Haemost. 5, 395-402.
24. Buras, J. A., Holzmann, B. and Sitkovsky, M. (2005) Animal models of sepsis: setting the stage. Nat. Rev. Drug. Discov. 4, 854-865.
25. Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., Czura, C. J., Roth, J., Warren, H. S., Fink, M. P., Fenton, M. J., Andersson, U. and Tracey, K. J. (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U.S.A. 101, 296-301.
26. Thalhamer, T., McGrath, M. A. and Harnett, M. M. (2008) MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford). 47, 409-414.
27. Bae, J. S. and Rezaie, A. R. (2011) Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood 118, 3952-3959.
28. Kim, D. C., Lee, W. and Bae, J. S. (2011) Vascular anti-inflammatory effects of curcumin on HMGB1-mediated responses in vitro. Inflamm. Res. 60, 1161-1168.
29. Miller, M. A., Meyer, A. S., Beste, M. T., Lasisi, Z., Reddy, S., Jeng, K. W., Chen, C. H., Han, J., Isaacson, K., Griffith, L. G. and Lauffenburger, D. A. (2013) ADAM-10 and-17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling. Proc. Natl. Acad. Sci. U.S.A. 110, E2074-2083.
30. Wang, H., Liao, H., Ochani, M., Justiniani, M., Lin, X., Yang, L., Al-Abed, Y., Metz, C., Miller, E. J., Tracey, K. J. and Ulloa, L. (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10, 1216-1221.